Aspen Aerogels (NYSE:ASPN) Sets New 52-Week High at $21.50

Aspen Aerogels, Inc. (NYSE:ASPN - Get Free Report) hit a new 52-week high on Thursday . The stock traded as high as $21.50 and last traded at $20.57, with a volume of 2639176 shares. The stock had previously closed at $15.22.

Analysts Set New Price Targets

Several equities research analysts have weighed in on the company. TheStreet upgraded Aspen Aerogels from a "d+" rating to a "c-" rating in a report on Wednesday, March 6th. HC Wainwright restated a "buy" rating and set a $20.00 price target on shares of Aspen Aerogels in a report on Wednesday, February 14th. Finally, Roth Mkm restated a "buy" rating and set a $22.00 price target on shares of Aspen Aerogels in a report on Tuesday. One investment analyst has rated the stock with a sell rating and four have given a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $19.00.

Aspen Aerogels Trading Up 56.7 %

The firm has a market cap of $1.83 billion, a PE ratio of -34.73 and a beta of 1.97. The company has a current ratio of 3.41, a quick ratio of 2.91 and a debt-to-equity ratio of 0.24. The business has a fifty day moving average price of $16.42 and a 200 day moving average price of $13.50.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last released its quarterly earnings results on Tuesday, February 13th. The construction company reported ($0.01) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.12) by $0.11. The firm had revenue of $84.22 million for the quarter, compared to the consensus estimate of $83.82 million. Aspen Aerogels had a negative return on equity of 10.47% and a negative net margin of 19.19%. During the same quarter last year, the business posted ($0.20) EPS. Analysts forecast that Aspen Aerogels, Inc. will post -0.24 EPS for the current year.

Institutional Trading of Aspen Aerogels

Hedge funds have recently modified their holdings of the business. Banque Cantonale Vaudoise raised its holdings in Aspen Aerogels by 37.5% during the first quarter. Banque Cantonale Vaudoise now owns 4,593 shares of the construction company's stock worth $81,000 after purchasing an additional 1,252 shares during the last quarter. Thompson Davis & CO. Inc. increased its position in Aspen Aerogels by 14.7% during the fourth quarter. Thompson Davis & CO. Inc. now owns 24,150 shares of the construction company's stock worth $381,000 after buying an additional 3,100 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank increased its position in Aspen Aerogels by 38.5% during the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 12,971 shares of the construction company's stock worth $205,000 after buying an additional 3,607 shares in the last quarter. Bouvel Investment Partners LLC increased its position in Aspen Aerogels by 4.3% during the fourth quarter. Bouvel Investment Partners LLC now owns 94,318 shares of the construction company's stock worth $1,488,000 after buying an additional 3,929 shares in the last quarter. Finally, Mitsubishi UFJ Kokusai Asset Management Co. Ltd. increased its position in Aspen Aerogels by 7.1% during the third quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. now owns 84,257 shares of the construction company's stock worth $725,000 after buying an additional 5,611 shares in the last quarter. 97.64% of the stock is owned by institutional investors and hedge funds.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.